Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06100133
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-25
First Post:
2023-09-29
Brief Title:
Treat Autosomal Dominant Polycystic Kidney Disease With Oral Ketone Ester
Sponsor:
Universitair Ziekenhuis Brussel
Organization:
Universitair Ziekenhuis Brussel
Study Overview
Official Title:
Treat Autosomal Dominant Polycystic Kidney Disease With Oral Ketone Ester
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ADKETONE
Brief Summary:
The investigators are running a study to see if a special drink called a ketone ester can help people with a type of kidney disease named Autosomal Dominant Polycystic Kidney Disease or ADPKD for short
The investigators want to find out
If its easy for patients to take this drink every day for about 2 months If its safe and doesnt cause any problems If it makes a difference in the size and function of the kidneys
Who can join
People between 16 to 70 years old who have ADPKD Those with a certain amount of kidney size and function People who havent been on specific diets or lost a lot of weight recently Women who are not breastfeeding and are using birth control People with a body weight that is not too low or too high
Who cannot join
People whove been on a high-fat diet or skipped meals for a while recently Those with other health conditions like diabetes or certain metabolic issues Anyone who has a problem with getting an MRI scan If participants are in another medical study right now
The study will happen in two Belgian hospitals and is supported by the UZ Brussels nephrology department The investigators hope to include 20 people and start in November 2023
The investigators want to find out
If its easy for patients to take this drink every day for about 2 months If its safe and doesnt cause any problems If it makes a difference in the size and function of the kidneys
Who can join
People between 16 to 70 years old who have ADPKD Those with a certain amount of kidney size and function People who havent been on specific diets or lost a lot of weight recently Women who are not breastfeeding and are using birth control People with a body weight that is not too low or too high
Who cannot join
People whove been on a high-fat diet or skipped meals for a while recently Those with other health conditions like diabetes or certain metabolic issues Anyone who has a problem with getting an MRI scan If participants are in another medical study right now
The study will happen in two Belgian hospitals and is supported by the UZ Brussels nephrology department The investigators hope to include 20 people and start in November 2023
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None